Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.

Haematologica · 2021 · PMC8168487 · PMID 33299234

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significanceP =0.065so close (0.05 < p ≤ 0.1)

6 The difference did not reach statistical significance for overall survival (3-year overall survival: 71.4% vs. 100%; P =0.065) ( Figure 2B ), perhaps due to low numbers.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.